Vilin Bio Med Limited
ListedSMEPharmaceuticals & Healthcare · NSE
Incorporated in 2005, Vilin Bio Med Limited is engaged in the domestic manufacturing of pharmaceutical products, supplying in bulk to pharmaceutical manufacturers, marketers, and traders who distribute them to end customers. The company’s product range includes Oral Liquids (Syrups, Suspensions, Dry Powders – both βeta and Non-βeta-Lactam), Tablets and Capsules (βeta and Non-βeta-Lactam), External Preparations, and Dry Powders. Vilin Bio Med operates its R&D center and manufacturing facility in Roorkee, Uttarakhand, ensuring quality and innovation in production. The company reported revenue of ₹1,121.91 lakhs in FY2022 and ₹1,171.88 lakhs in FY2021.
Price Band
₹30
Issue Size
₹12.00 Cr
Lot Size
4000 shares
GMP
—
Est. Listing
₹30
at current GMP
Subscribed
2.82x
overall
Open
16 Jun 2023
Close
21 Jun 2023
Allotment
26 Jun 2023
Refund
27 Jun 2023
Demat Credit
28 Jun 2023
Listing
30 Jun 2023
Last updated 12 days ago
Key Highlights
- •Leading player in the Pharmaceuticals & Healthcare segment
- •Price band established at ₹30 - ₹30 per equity share
- •Minimum bid lot is 4000 shares
- •Estimated listing target of ₹30 based on current grey market activity